Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Open Label Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection

NCT04411667 is registered in ClinicalTrials.gov with George Sakoulas, MD as lead sponsor.

NCT NCT04411667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04411667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Open Label Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection
Lead sponsor
George Sakoulas, MD
Phase
Phase 4
Overall status
Completed
Start date
April 28, 2020
Completion date
June 23, 2020
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2